Stride (LRN) is down -46.8%, or -$71.92 to $81.61.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRN:
- Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
- Stride price target lowered to $130 from $159 at Morgan Stanley
- Stride price target lowered to $125 from $175 at Canaccord
- Stride’s Long-Term Potential Remains Intact Despite Short-Term Challenges
- Stride downgraded to Market Perform from Outperform at BMO Capital